Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
John Reed
Biotech
J&J's Reed takes home $20M-plus payday in his first year
In 2022, the highest-paid R&D executive made $12.2 million. John Reed, M.D., Ph.D., of J&J is telling the rest of the field to hold his beaker.
Max Bayer
Mar 13, 2024 11:04am
UPDATED: Reed relinquishes Sanofi’s R&D reins, heads to J&J
Feb 13, 2023 5:17pm
Sanofi's head of R&D sheds light on SERD fail
Aug 17, 2022 11:20am
Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Nov 2, 2020 3:50am
Sanofi bags NK cells to boost effect of rival to J&J's Darzalex
Jul 8, 2020 8:20am
Sanofi nabs speedy review of sutimlimab
May 15, 2020 8:15am
